van den Akker Peter C, van Essen Anthonie J, Kraak Marian M J, Meijer Rowdy, Nijenhuis Miranda, Meijer Gonnie, Hofstra Robert M W, Pas Hendri H, Scheffer Hans, Jonkman Marcel F
Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
J Dermatol Sci. 2009 Oct;56(1):9-18. doi: 10.1016/j.jdermsci.2009.06.015. Epub 2009 Aug 8.
The current classification of recessive dystrophic epidermolysis bullosa (RDEB) comprises two major subtypes: 'severe generalized RDEB' (RDEB-sev gen) with early-onset, extensive, generalized blistering and scarring, complete absence of type VII collagen, and bi-allelic COL7A1 null mutations; milder 'generalized other RDEB' (RDEB-O) with reduced-to-normal type VII collagen expression, and non-null genotypes.
To search for previously unrecognized phenotype-genotype correlations in 33 Dutch RDEB families.
We analyzed extensive clinical follow-up data, available for all patients up to 19 years, detailed type VII collagen immunostaining and genotypes, and correlated clinical phenotype to molecular phenotype and genotype.
We identified 20 novel COL7A1 mutations. In 14 of 15 RDEB-sev gen patients type VII collagen was completely absent, one had strongly reduced type VII collagen, and all carried bi-allelic null mutations. Five of 11 RDEB-O patients developed pseudosyndactyly of the fingers preceded by skin atrophy and flexion contractures later in childhood and adolescence. All five had esophageal involvement and growth retardation. Type VII collagen immunostaining ranged from strongly reduced to slightly reduced in RDEB-O patients with pseudosyndactyly, whereas RDEB-O patients without pseudosyndactyly had slightly reduced to normal type VII collagen staining. There was no difference in genotypes between both groups, although we unexpectedly found bi-allelic null mutations in two of five RDEB-O patients with pseudosyndactyly.
Pseudosyndactyly occurs in approximately half of RDEB-O patients when type VII collagen is strongly reduced. The prognosis in RDEB cannot always be simply predicted from the COL7A1 genotype.
隐性营养不良型大疱性表皮松解症(RDEB)的当前分类包括两个主要亚型:“严重全身性RDEB”(RDEB-sev gen),其具有早发性、广泛性、全身性水疱和瘢痕形成,完全缺乏VII型胶原蛋白,以及双等位基因COL7A1无效突变;症状较轻的“全身性其他RDEB”(RDEB-O),其VII型胶原蛋白表达降低至正常,且基因型非无效。
在33个荷兰RDEB家族中寻找先前未被认识到的表型-基因型相关性。
我们分析了所有患者至19岁的广泛临床随访数据、详细的VII型胶原蛋白免疫染色和基因型,并将临床表型与分子表型和基因型进行关联。
我们鉴定出20个新的COL7A1突变。在15例RDEB-sev gen患者中的14例中,VII型胶原蛋白完全缺失,1例VII型胶原蛋白严重减少,且所有患者均携带双等位基因无效突变。11例RDEB-O患者中有5例在儿童期和青春期后期出现手指假性并指,之前有皮肤萎缩和屈曲挛缩。所有5例患者均有食管受累和生长发育迟缓。有假性并指的RDEB-O患者的VII型胶原蛋白免疫染色范围从严重减少到轻度减少,而无假性并指的RDEB-O患者的VII型胶原蛋白染色则从轻度减少到正常。两组患者的基因型没有差异,尽管我们意外地在5例有假性并指的RDEB-O患者中的2例中发现了双等位基因无效突变。
当VII型胶原蛋白严重减少时,约一半的RDEB-O患者会出现假性并指。RDEB的预后不能总是简单地从COL7A1基因型来预测。